keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pomalidomide-PEG2-CO2H is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a 2-unit PEG linker.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 60.00 | |
10 mg | In stock | $ 88.00 | |
25 mg | In stock | $ 147.00 | |
50 mg | In stock | $ 263.00 | |
100 mg | In stock | $ 385.00 | |
200 mg | In stock | $ 576.00 |
Description | Pomalidomide-PEG2-CO2H is a synthetic E3 ligase ligand-linker conjugate containing a Pomalidomide-based cereblon ligand and a 2-unit PEG linker. |
In vitro | PROTACs contain two distinct ligands, one for the E3 ubiquitin ligase and the other for the target protein, linked by a linker[1]. |
Synonyms | Pomalidomide 4'-PEG2-acid, Pomalidomide-PEG2-C2-acid |
Molecular Weight | 433.41 |
Formula | C20H23N3O8 |
CAS No. | 2140807-17-4 |
keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 200 mg/mL (461.5 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pomalidomide-PEG2-CO2H 2140807-17-4 PROTAC E3 Ligase Ligand-Linker Conjugate Pomalidomide 4'-PEG2-acid Pomalidomide-PEG2-C2-acid inhibitor inhibit